Overall rank by patents
#24,947
of 50,000 tracked assignees
USPTO PatentsView assignee record - 11 granted patents across 5 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE).
The verdict
According to USPTO PatentsView, Optimotion ranks #24,947 of 50,000 tracked US assignees by granted-patent volume, with 11 patents across 5 technology areas.
USPTO PatentsView assignee plate
Corpus R24947 · US Corporation #24,947 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Olympic Ophthalmics, Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Optimotion Implants · this assignee
35 score
3D Lighting Innovati… · lowest
7 score
What this shows Optimotion's Innovation Score is 35.2/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Optimotion Implants Llc is a focused PatentsView assignee: 5 CPC subclasses with 72.7% of grants classified under A61F (FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICE). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2019. By volume, Optimotion sits between Olympic Ophthalmics, Inc. and Own Data Company Ltd.
Optimotion Implants Llc shows 6 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Olympic Ophthalmics, Inc.
11 patents
Onset Medical, Inc.
11 patents
Open Access Technology International, Inc.
11 patents
Open Drives, Inc.
11 patents
Optronics International, LLC
11 patents
Oriel Therapeutics, Inc.
11 patents
Orna Therapeutics, Inc.
11 patents
Own Data Company Ltd
11 patents
Optimotion Implants LLC
11 patents
What this shows Optimotion holds 11 patents at rank #24,944, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #24,944 in granted patent volume.
Other assignees with the most granted patents in Optimotion's primary technology class.
Optimotion's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
35 Top 50% higher than 50% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 9.1% |
| 2021 | 3 | 27.3% |
| 2022 | 1 | 9.1% |
| 2023 | 2 | 18.2% |
| 2024 | 3 | 27.3% |
| 2025partial year | 1 | 9.1% |
Top 5 of 5 technology areas
Overall rank by patents
#24,947
of 50,000 tracked assignees
35.2 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.